| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $212.7M | +1.6% |
| Cost of Revenue | $42.9M | +4.5% |
| Gross Profit | $169.8M | +0.9% |
| R&D Expense | $20.3M | -1.5% |
| SG&A Expense | $62.7M | +12.6% |
| Operating Income | -$54.2M | +2.8% |
| Interest Expense | $5.3M | +1.2% |
| Income Tax | $0 | — |
| Net Income | -$59.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | -5.7% |
| Short-term Investments | $37.7M | -41.5% |
| Accounts Receivable | $42.2M | +3.3% |
| Inventory | $36.0M | -8.2% |
| Current Assets | $132.1M | -18.2% |
| Total Assets | $190.6M | -12.2% |
| Current Liabilities | $30.6M | -12.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +57.0% |
| Capital Expenditures | $13.5M | +16.6% |
| Investing Cash Flow | $13.3M | -62.5% |
| Financing Cash Flow | $2.1M | +1198.1% |
| Free Cash Flow | -$29.5M | +39.5% |
| -5.8% |
| EPS (Basic) | -$0.93 | -3.3% |
| EPS (Diluted) | -$0.93 | -3.3% |
| Long-term Debt |
| $55.6M |
| +4.3% |
| Total Liabilities | $103.2M | -0.9% |
| Stockholders' Equity | $87.3M | -22.6% |